Fulcrum Therapeutics, Inc. (FULC)
3.725
-0.06
(-1.59%)
USD |
NASDAQ |
Sep 25, 15:02
Fulcrum Therapeutics Cash and Short Term Investments (Quarterly) : 318.84M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 318.84M |
| March 31, 2026 | 333.32M |
| December 31, 2025 | 352.31M |
| September 30, 2025 | 200.64M |
| June 30, 2025 | 214.11M |
| March 31, 2025 | 226.60M |
| December 31, 2024 | 241.02M |
| September 30, 2024 | 257.23M |
| June 30, 2024 | 273.78M |
| March 31, 2024 | 213.31M |
| December 31, 2023 | 236.22M |
| September 30, 2023 | 257.09M |
| June 30, 2023 | 278.16M |
| March 31, 2023 | 297.84M |
| December 31, 2022 | 202.92M |
| September 30, 2022 | 221.79M |
| Date | Value |
|---|---|
| June 30, 2022 | 168.97M |
| March 31, 2022 | 195.11M |
| December 31, 2021 | 218.16M |
| September 30, 2021 | 240.34M |
| June 30, 2021 | 125.55M |
| March 31, 2021 | 143.86M |
| December 31, 2020 | 112.91M |
| September 30, 2020 | 127.02M |
| June 30, 2020 | 131.74M |
| March 31, 2020 | 81.21M |
| December 31, 2019 | 96.71M |
| September 30, 2019 | 101.60M |
| June 30, 2019 | 49.63M |
| March 31, 2019 | 62.45M |
| December 31, 2018 | 72.80M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 2.244M |
| CNBX Pharmaceuticals, Inc. | 0.0095M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 567.90M |
| Definium Therapeutics, Inc. | 1.084B |